BusinessPakistan’s Economy Grows by 3.7% in FY26: A Record Size but a Missed Target
Pakistan's economy grew by 3.7% in FY26, reaching a record $452.1 billion in size, though it missed the 4.2% government ...
Read More →Business
BusinessPakistan’s Parliament Passes Massive Finance Bill 2026 Amid Fierce Opposition Walkout
Pakistan's National Assembly has passed the Finance Bill 2026, setting an ambitious revenue target of Rs15.264 trillion ...
Read More →
BusinessNext-Generation Live Biotherapeutics: Engineered Microbiome Consortia Target Metabolic Syndrome
Next-generation Live Biotherapeutic Products (LBPs) and engineered microbes are revolutionizing the treatment of metabol...
Read More →
BusinessBrain-Computer Interfaces: Endovascular Stentrodes Restore Communication in ALS Patients
Endovascular Brain-Computer Interfaces (BCIs), such as the Synchron Stentrode, are restoring communication and digital c...
Read More →
BusinessSenolytics in Clinical Trials: Clearing Senescent Cells to Reverse Frailty and Idiopathic Pulmonary Fibrosis
Senolytics, drugs designed to clear senescent "zombie" cells, are showing promising results in clinical trials for age-r...
Read More →
BusinessUniversal Influenza Vaccine: mRNA and Nanoparticle Platforms Target Conserved Stalk for Broad Protection
Medical researchers are developing a universal influenza vaccine using mRNA and nanoparticle platforms to target the con...
Read More →
BusinessAI-Discovered Antibiotics: Machine Learning Identifies Novel Molecular Scaffolds Against ESKAPE Pathogens
Artificial intelligence is revitalizing antibiotic discovery by identifying novel molecular scaffolds and designing new ...
Read More →
BusinessXenotransplantation Milestones: 10-Gene Edited Pig Kidneys Overcome Hyperacute Rejection in Human Trials
Medical researchers have successfully transplanted 10-gene edited pig kidneys into human recipients, overcoming the hist...
Read More →
BusinessIn Vivo CRISPR Base Editing: Verve-102 Offers 'One-and-Done' Permanent Cholesterol Reduction
Verve Therapeutics' in vivo CRISPR base editing program, VERVE-102, utilizes lipid nanoparticles to permanently disable ...
Read More →
BusinessBeyond Weight Loss: GLP-1 Agonists Demonstrate Profound Cardio-Renal Protection in Landmark Trials
Landmark trials like SELECT and FLOW have proven that GLP-1 agonists offer profound cardiovascular and renal protection,...
Read More →